Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial
Titel:
Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial
Auteur:
O'Brien, Sarah H Rodriguez, Vilmarie Lew, Glen Newburger, Jane W Schultz, Corinna L Orgel, Etan Derr, Kimberly Ranalli, Mark A Esbenshade, Adam J Hochberg, Jessica Kang, Hyoung Jin Dinikina, Yulia Mills, Donna Donovan, Mark Dyme, Joshua L Favatella, Nicholas A Mitchell, Lesley G